Pfizer HER2 Expression
Tempus collaborates with Pfizer to further profile HER2 expression across various cancers.
Apr 30, 2024
Life Sciences
Multi-Indication
Case Study
Related content
Tempus collaborates with Pfizer to further profile HER2 expression across various cancers.
Related content